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ABSTRACT 
TBX5 plays a critical role in heart and forelimb development. Mutations in TBX5 cause 
Holt-Oram syndrome, an autosomal dominant condition that affects the formation of the heart 
and upper-limb. Several studies have provided significant insight into the role of TBX5 in 
cardiogenesis; however, how TBX5 activity is regulated by other factors is still unknown. 
Here we report that histone acetyltransferases KAT2A and KAT2B associate with TBX5 and 
acetylate it at Lys339. Acetylation potentiates its transcriptional activity and is required for 
nuclear retention. Morpholino-mediated knockdown of kat2a and kat2b transcripts in 
zebrafish severely perturb heart and limb development, mirroring the tbx5a knockdown 
phenotype. The phenotypes found in MO-injected embryos were also observed when we 
introduced mutations in the kat2a or kat2b genes using the CRISPR-Cas system. These 
studies highlight the importance of KAT2A and KAT2B modulation of TBX5 and their 
impact on heart and limb development. 
INTRODUCTION 
TBX5 is essential for heart and fore-limb development and mutations in this gene result in 
defective structures (Li et al. 1997, Basson et al. 1997). During heart development a number 
of cardiac transcription factors, most notably GATA4 and MEF2C, physically associate and 
functionally cooperate with TBX5 in order to control and regulate many processes taking 
place during cardiogenesis (Garg et al. 2003, Ghosh et al. 2009). In addition to this, recent 
studies suggest that overexpression of these three factors is sufficient to reprogram fibroblast 
cells to cardiomyocyte-like cells (Ieda et al. 2010). Even though the role of TBX5 in cardiac 
development and reprogramming has been extensively studied, how TBX5 activity is 
regulated by other factors remains largely unknown. 
Acetylation of histone and non-histone proteins regulates cellular physiology and affects 
cellular proliferation, growth and differentiation (Parrie et al. 2013). The acetylation and 
deacetylation status of histones ultimately controls muscle differentiation and cardiac 
hypertrophy (McKinsey et al. 2001, Backs and Olson 2006). Their activity on defined non-
histone proteins has also been described (Thisse and Thisse 2008, Chernyavskaya et al. 
2012). Two major histone acetyltransferases (HATs) in mammals are KAT2B (PCAF) and 
p300. Although functionally similar they have distinct roles in muscle differentiation (Puri et 
al. 1997). p300 is essential for embryogenesis and mice lacking a functional p300 gene die 
between 9 and 11.5  days of gestation. These knockout mice exhibit defects of cardiac muscle 
differentiation and trabeculation (Yao et al. 1998). Furthermore, transgenic expression of 
p300 in the adult heart results in hypertrophy and heart failure (Yanazume et al. 2003). Kat2a, 
a paralogue of Kat2b shares similar sequences and enzymatic activity. Although they are 73% 
identical and possess similar acetyltransferase activity, they have distinct but overlapping 
roles in mouse embryogenesis. Kat2a-null embryos die during embryogenesis, whilst Kat2b 
knockout mice show no obvious phenotype. Combined loss of Kat2a and Kat2b in mice leads 
to even more severe developmental defects, suggesting a partial functional redundancy 
between Kat2a and Kat2b in vivo (Xu et al. 2000). The obvious functional disparity between 
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Kat2b and Kat2a may be partly due to their differential expression pattern during early 
embryogenesis, as Kat2b is expressed slightly later than Kat2a (Yamauchi et al. 2000).  
Kat2b and Kat2a are ubiquitously expressed and most abundant in skeletal muscle. The 
former is also highly abundant in the heart, whereas the latter is highly abundant in pancreas 
(Yang et al. 1996). 
Acetylation of cardiac transcription factors GATA4 and MEF2C is important for the 
differentiation of cardiomyocytes (Miska et al. 2001, Kuninger et al. 2007). Indeed, 
acetylation of GATA4 triggers the differentiation of embryonic stem cells into cardiac 
myocytes (Borghi et al. 2001). Recent studies suggest  p300 and Hdac3 regulate early 
cardiogenesis by modulating Tbx5 activity (Lewandowski et al. 2014). Here we report that 
both KAT2A and KAT2B physically associate with and acetylate TBX5 at Lys339. 
Acetylation augments its transcriptional activity and is required for its nuclear retention. 
Morpholino-mediated knockdown and CRISPR-Cas-mediated knockout of kat2a and kat2b 
in zebrafish produces both heart and fin phenotypes similar to that observed in tbx5a 
morphants. This study reveals a role for KAT2A and KAT2B and their link with TBX5, in 
heart and limb development. 
RESULTS 
TBX5 is acetylated by both KAT2A and KAT2B  
In view of the role of p300 in acetylation and transcriptional regulation of GATA4, MEF2C 
and TBX5 we investigated whether TBX5 could be acetylated and whether this has 
functional consequences. Cos7 cells were transiently transfected with plasmids encoding 
TBX5-FLAG along with KAT2B-HA or p300-FLAG. The FLAG-tagged TBX5 proteins 
were affinity purified from the cell lysates using anti-FLAG-agarose beads. The bound 
proteins were eluted using sample buffer, fractionated on SDS-PAGE gels and subsequently 
immunoblotted with anti-acetylated lysine antibody. As shown in Fig. 1A, TBX5 was 
specifically acetylated by KAT2B, whereas p300 failed to do so. Treatment with histone 
deacetylase inhibitor Trichostatin A (TSA) enhanced TBX5 acetylation. In order to further 
confirm the TBX5 acetylation by KAT2B, we also performed in vitro acetylation assays in 
cell-free extracts using purified MBP-TBX5 and KAT2B proteins. The results suggest that 
MBP- TBX5 is acetylated by KAT2B in vitro (Fig. S1). 
To demonstrate the association between TBX5 and KAT2B, pull-down experiments were 
conducted on the cell extracts using anti-FLAG-agarose beads. Fig. 1B shows FLAG-tagged 
TBX5 specifically pulled down HA-KAT2B from the lysate in which both proteins were 
expressed suggesting their physical association. In addition we examined whether KAT2A, a 
functional homologue of KAT2B could also acetylate TBX5. Similar co-expression of 
KAT2A and TBX5 in Cos7 cells resulted in acetylation of TBX5 (Fig. 1C) and pull-down 
assays also identified their physical interaction (Fig. 1D).  
In promoter-reporter assays, cotransfection of plasmids encoding TBX5, KAT2B and the 
reporter plasmid pGL3-MYH6-I resulted in significant enhancement of TBX5-mediated 
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transcription. Likewise, KAT2A significantly enhanced the TBX5-mediated transcription 
from the MYH6 promoter (Fig. 1E). We also performed similar reporter assays on two other 
TBX5 target promoters: ANF and CX40. The results suggest that the ANF promoter activity 
is significantly enhanced in presence of KAT2B and TBX5 (Fig. 1F), whereas Cx40 
promoter (-1190/+121-Luc) was not TBX5 responsive in this cell line (data not shown). 
Overall, these experiments suggest that the acetylation of TBX5 is a conserved function 
shared between the KAT2-family of proteins.   
Mapping the acetylation residue in TBX5  
To map the acetylation residue in TBX5, the web-based prediction sites PredMod, PAIL and 
PHOSIDA were used. Whilst the predictions vary considerably in each case, Lys234 was 
picked up by all three sites (Fig. S2, A-C). However, conservative substitution of lysine 234 
to arginine did not eliminate acetylation suggesting that Lys234 is not the key lysine residue 
for acetylation (Fig. S2D).  
Next, we attempted to derive an acetylation motif for KAT2B and KAT2A. We searched in 
the literature for proteins that are acetylated by KAT2B and KAT2A, extracted short stretches 
of amino acid sequence either side of the key lysine residues and aligned them.  Since 
previous studies suggested an acetylation motif of 3-4 amino acids we set a sliding window 
of six amino acids to the N-terminus and C-terminus of the relevant lysine residue.  
Frequency plot analysis of 25 acetylated peptide sequences suggested an enrichment of a 
lysine residue at position -3, a lysine or arginine at position +1 and a serine, proline or lysine 
at +2 (Fig. 2A and Fig. S3A). Overall, the alignment provided a lysine rich consensus motif 
K-X-X-K-K/R-P/L/K (where X denotes any amino acids). For the control, we randomly 
picked similar lengths of peptide sequences around a lysine residues from 25 non-acetylated 
proteins in the UniProt database and no such enrichment was found (Fig. S3B). 
On close scrutiny, we observed that only one third of the 25 targets contain the full consensus 
and many contain a partial motif either K-X-X-K or K-K/R-P/L/K. These two partial motifs 
also overlap with the recognition sequences obtained for p300 and GCN5 (Gu and Roeder 
1997, Rojas et al. 1999). Thus, we noted a significant enrichment of basic amino acid 
residues lysine or arginine and aliphatic amino acids proline or leucine around the key 
acetylated lysine. 
Next, we examined TBX5 but were unable to find any obvious full-length acetylation motif. 
However, TBX5 does contain two partial motifs; K-R-K and K-K-P at positions 325-327 and 
339-341, respectively (Fig. 2B). In order to ascertain whether any of these lysine residues 
could be acetylated, we made conservative substitutions of these lysine residues to arginine. 
We generated mutants K325R or K327R in the KRK motif, and K339R or K340R for the 
KKP motif and analysed whether they could be acetylated by KAT2B in Cos7 cells. Mutants 
K325R and K327R in KRK were efficiently acetylated by KAT2B (Fig. 2C).  The mutant 
K340R was also acetylated by KAT2B.  However, mutation of K339R completely eliminated 
acetylation indicating that the lysine 339 is the key residue for acetylation of TBX5 (Fig. 2D), 
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Figure 1. TBX5 associates with, and is acetylated by KAT2B and KAT2A. (A-D) Western blots of pull down assays show 
that (A) KAT2B acetylates TBX5 (lane 4 and 6), whereas p300 does not (lanes 3 and 5). TSA enhances the acetylation level 
of TBX5 (lane 6). (B) TBX5 and KAT2B physically associate. (C) TBX5 is acetylated by KAT2A. (D) Association of 
TBX5 and KAT2A.	(E) and (F) Reporter assays show that KAT2B and KAT2A enhance the TBX5-mediated transcription 
on a MYH6 promoter (E) and on an ANF promoter (F). Results are from three independent experiments. Error bars represent 
SD, * P <0.05 (Student’s t test). IP- immunoprecipitation, IB-immunoblot and TSA-Tricostatin A. 
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an effect that was also seen in H9C2 cells (Fig. S3C). KAT2A, which also acetylates TBX5, 
failed to acetylate the mutant K339R as well (Fig. 2F). To determine whether TBX5K339R 
still retains its ability to interact with KAT2B, we performed pull-down assays and the result 
suggests that the mutant TBX5 K339R physically interacts with KAT2B (Fig. S3D). 
Interestingly, K339 is well conserved among TBX5 proteins (Fig. 2B) which probably 
suggests its evolutionary significance. KAT2B also failed to potentiate the transcriptional 
activity of the K339R mutant in reporter assays (Fig. 2E), suggesting that acetylation indeed 
enhanced the transcriptional potential of TBX5. We also checked the native transcriptional 
activity of TBX5K325R, TBX5K327R, TBX5K339R and TBX5K340R on the MYH6 
promoter. K325R, K327R and K340R mutants didn’t show any significant change in their 
transcriptional activity in comparison with TBX5 WT. However, a significant reduction was 
observed in the K339R mutant (Fig. S3E). 
Overall, these experiments suggest that TBX5 is acetylated at lysine 339, and that this residue 
is critical to potentiate its transcriptional activity. 
Acetylation of TBX5 and nucleocytoplasmic shuttling  
TBX5 is a shuttling protein. It has two nuclear localization signal domains; NLS1 (aa78-90) 
and NLS2 (aa325-340) that act in a cooperative fashion to mediate nuclear translocation 
(Collavoli et al. 2003). Also, it has a nuclear export signal (NES, aa152-160) which is 
recognized by the CRM1 export protein (Kulisz and Simon 2008) (Fig. 3A). Since the 
acetylation residue K339 is located within the NLS2 we investigated whether acetylation 
would have an impact on TBX5 nuclear localization on two different cell lines: Cos7 and 
C2C12 cells. In Cos7 cells, wild type TBX5 was expressed exclusively in the nucleus in 95% 
of cells counted. In the case of the acetyl-deficient mutant TBX5-K339R, only 24% of the 
cells showed a TBX5-K339R nuclear localization, whereas 76% showed a cytoplasmic 
localization (both nuclear and cytoplasmic or predominantly cytoplasmic). In most cells we 
also found accumulation of TBX5-K339R around the outer nuclear membrane. We found 
similar results when we transfected TBX5-WT or TBX5-K399R in C2C12 cells: TBX5-WT 
showed an exclusive nuclear localization in 94% of C2C12 cells, whereas only a 17% of cells 
showed a nuclear TBX5-K339R localization (83% of the cells presented a cytoplasmic 
localization) (Fig. 3B and S4A). 
In order to confirm that this impairment in cellular localization is indeed due to the lack of 
acetylation, we treated TBX5 WT-transfected Cos7 cells with Garcinol, a potent inhibitor of 
HATs KAT2B and p300. When cells were treated with 20 µM of Garcinol, only 50% of them 
showed a nuclear TBX5-WT localization, whereas 50% showed a cytoplasmic distribution 
(Fig. S4B). 
These results suggested that the lack of acetylation in the mutant TBX5-K339R leads to an 
impaired cellular localization. In order to determine whether TBX5 acetylation is required for 
its nuclear import or for nuclear retention, we treated cells transfected with either TBX5-WT  
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Figure 2. Mapping the acetylation residue in TBX5. (A) The sequence logo plot shows the frequencies of amino acids at 
positions -6 to +6 with reference to the acetylated lysine residue. Arrows show the positions of enrichment.  (B) Alignment 
of TBX5 protein sequences showing conservation of the KRK and KKP motifs. Hs-Human, Pt-chimpanzee, Mm-mouse, Cl-
Dog, Gg-chicken, Xl-xenopus and Dr-zebrafish. (C and D) Pull-down assays to map the key lysine residue for acetylation in 
KRK (C) and KKP (D) motifs. (E) Reporter assay shows KAT2B failed to potentiate the transcriptional activity of the 
acetyl-deficient mutant protein TBX5 K339R on a MYH6 promoter. Results are from three individual experiments. Error 
bars represent SD, *P<0.05. (F) Pull-down assay showing KAT2A does not acetylate TBX5K339R. 
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or TBX5-K339R with leptomycin B, a potent inhibitor of the exportin CRM1, which 
mediates TBX5 nuclear export (Kulisz and Simon 2008). Following leptomycin B treatment, 
we found that TBX5-K339R remained inside the nucleus in 96% of Cos7 cells analysed and 
in 85% of C2C12 cells, both in contrast to the predominantly cytoplasmic localization of 
TBX5-K339R in non-treated cells. Treatment of TBX5-WT with leptomycin B did not have 
any effect on its normal nuclear localization (Fig. 3C and S4A). We also checked the 
potential co-localization of TBX5-K339R and endogenous CRM1 outside the nucleus. 
Immunofluorescence staining of TBX5-K339R and endogenous CRM1 showed that they 
both co-localize outside the nucleus, mainly around the outer nuclear membrane. When 
TBX5-WT was transfected, or when TBX5-K339R was treated with Leptomycin B, both 
TBX5 and CRM1 were localized strictly inside the nucleus (Fig. S4C). 
Finally, we also performed in vitro interaction studies on CRM1 and TBX5-WT or TBX5-
K339R. Following transfection of TBX5-WT-FLAG or its mutant variant TBX5-K339R-
FLAG in Cos7 cells (in which CRM1 is ubiquitously expressed), a pull-down assay revealed 
that the acetyl-deficient variant TBX5-K339R presents higher affinity for the CRM1 protein 
than its WT counterpart (Fig. 3D and 3E). 
Overall, these results indicate that acetylation of TBX5 is required for its nuclear retention 
and to maintain a critical concentration of TBX5 inside the nucleus, whereas lack of 
acetylation promotes its nuclear export via the CRM1-pathway.  
Knockdown of kat2a and kat2b in zebrafish produce heart defects  
Since both KAT2A and KAT2B interact with and acetylate TBX5, we looked for their in vivo 
functional impact on heart and limb development in zebrafish. Zebrafish KAT proteins share 
a high degree of similarity with their human and murine counterparts (84% and 85% for 
KAT2A, and 81% and 80% for KAT2B respectively) as revealed by amino acid sequence 
analysis using the ClustalW2 software (Fig. S5A). In addition to this, we checked the 
expression pattern of kat2a and kat2b in zebrafish, for which we dissected out head/thorax 
containing heart and tail regions at different stages of development.  RNAs were extracted 
and RT-PCR analysis revealed expression of both kat2a and kat2b in the heart and tail 
regions throughout developmental stages 36-72hpf (Fig. S5B). ISH analysis using kat2a and 
kat2b probes on 48 hpf embryos indicated that both of them are mainly expressed in the head 
and cardiac region in an ubiquitous manner, as expected. We also detected expression of both 
transcripts in the tail region and in the pectoral fins (Fig. S5C). 
To analyse the in vivo roles of kat2a and kat2b we carried out morpholino-mediated 
knockdown studies in zebrafish with both translation blocking and splice blocking 
morpholinos (mismatch morpholinos were employed as controls). The embryos were 
screened for heart phenotypes and based on the severity of heart defects they were assigned 
to one of three categories: normal, mild or severe.	In normal embryos, both the atrium and the 
ventricle were clearly defined and tightly packed into a figure eight configuration. In the mild 
phenotype the atrium and ventricle were clearly distinguishable, but looping was noticeably 
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relaxed and slight pericardial oedema was usually seen, as well as a slight reduction in the 
rate of heart beat. 
	
Figure 3. Acetylation and nucleocytoplasmic shuttling of TBX5. (A) Schematic representation of TBX5. NLS1-Nuclear 
Localization Signal domain 1, NLS2-Nuclear Localization Signal domain 2 and NES- Nuclear Export Signal. (B) 
Representative images of the cellular distribution of TBX5-WT and TBX5-K339R in both COS7 and C2C12 cells. (C) The 
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effect of leptomycin B on nuclear/cytoplasmic distribution of TBX5-WT and TBX5-K339R. (D) Pull-down assay showing 
increased affinity of mutant protein TBX5K339R for CRM1. (E) Quantification of CRM1 protein pull-down by wildtype 
(TBX5-FLAG) and acetyl-deficient mutant protein (TBX5K339R-FLAG). Results are mean ± SD from 3 individual 
experiments, *P<0.001, Student’s t test. 
In the severe phenotype the atrium and ventricle were hardly distinguishable and they were 
irregular in shape and/or size, and the heart in general was stretched to a thin tube. Looping 
was lost, a moderate-large pericardial oedema is observed and the heart rate was notably 
slower. 
Overall, kat2a and kat2b morpholinos produced very similar cardiac developmental defects to 
those observed in tbx5a morphants (Fig. 4A). In both kat2a and kat2b knockdown embryos 
heart looping was interrupted and pericardial oedema was seen, as was altered chamber 
morphology. In the case of kat2a and kat2b single knockdowns, we found that 44% and 45% 
of injected embryos presented a mild heart phenotype respectively, whereas only a 12% and 
20% showed a severe phenotype. However, in tbx5a knockdown 57% of the injected 
embryos showed a severe heart phenotype, with only 19% of them presenting a mild 
phenotype. A similar proportion of mild and severe phenotypes was found when we injected 
both kat2a and kat2b morpholinos together (29% and 48% respectively), thus supporting a 
potential compensatory effect between kat2a and kat2b (Fig. 4B). Defects were also seen 
affecting other areas (e.g fins, somite, brain, etc) in kat2a and kat2b knockdowns.  
To demonstrate kat2a and kat2b knockdown, RT-PCR was performed on the RNA samples 
obtained from the splice knockdown morphants. Agarose gel electrophoresis confirmed that 
splicing of exon 2 was affected in kat2a and kat2b transcripts of the morphants. In both cases 
a normal size allele (345bp for kat2a and 342bp for kat2b respectively) and a short isoform 
lacking exon 2 (221bp for kat2a and 204bp for kat2b respectively) were detected (Fig. 4C-D). 
The spliced products were also sequence verified. Overall, these experiments suggest that 
kat2a/2b knockdown produced heart phenotype similar to those in tbx5a morphants, 
suggesting a genetic link between them and the presence of a compensatory effect between 
kat2a and kat2b. 
Knockout of kat2a and kat2b in zebrafish phenocopies the heart defects found in kat2a 
and kat2b knockdowns 
To validate the kat2a, kat2b and tbx5a loss-of-function phenotypes, we generated F0 mutants 
for each of these genes using the CRISPR-Cas genome-editing technology. sgRNAs targeting 
kat2a, kat2b and tbx5a exonic regions were designed using the CHOPCHOP web tool (Fig. 
S6A) and injected alongside Cas9 protein into 1-cell stage zebrafish embryos (Cas9-only 
injected embryos were used as negative controls). Screening 48 hpf revealed that 43% of 
embryos injected with Cas9 and kat2a sgRNA, and 39% of embryos injected with Cas9 and 
kat2b sgRNA, presented a mild heart phenotype very similar to that found in their 
knockdown counterparts; whereas 6% and 5% presented a severe phenotype respectively. 
Injection of Cas9 and a tbx5a sgRNA led to 17% of the embryos showing a mild phenotype, 
and 43% with a severe phenotype (Fig. 5A and 5B). In order to confirm the presence of 
mutations in embryos showing a cardiac phenotype, we performed a T7 assay and Sanger 
11	
	
sequencing. These two approaches confirmed the presence of indels in 95-100% of analysed 
embryos for each gene (n=40), whereas injected embryos presenting a normal cardiac 
phenotype did not harbour any mutation in 90-95% of the cases (n=20 for each gene) (Fig. 
S6B and S6C). Analysis of  
	
Figure 4. Morpholino-mediated knockdown of kat2a and kat2b in zebrafish present a heart phenotype similar to tbx5a 
knockdown.  (A) Zebrafish embryos showing the effect of tbx5, kat2a and kat2b morpholinos on heart development. 
Embryos were categorized as mild or severe based on the severity of the cardiac phenotype	 (V=ventricle, A=atrium, 
PE=pericardial oedema). (B) Histogram showing the distribution of cardiac phenotypes based on severity in injected 
embryos (n=200 embryos per injection batch). (C) Design of the splice junction morpholinos at intron 1 and exon 2 
boundaries of kat2b and -2a. (D and E) Agarose gels showing the specific effect of splice blocking morpholinos against 
kat2a (D) and kat2b (E). Scale bar = 200 µm. 
individual alleles indicated that in embryos presenting a cardiac phenotype, the rate of 
mutagenesis was around 80-90% with each of the sgRNAs, suggesting the presence of bi-
allelic mutations in a substantial number of cells (Fig. 5B and Fig. S6C). 
Next, we sought further insight into the cardiac phenotype present in kat2a and kat2b KO in 
comparison to the tbx5a KO phenotype. In-situ hybridization using a cmlc2 probe revealed 
that cardiac chamber morphology was slightly altered in mild embryos, and severely affected 
in severe embryos. Cardiac looping angle measurement indicated slight relaxation in kat2a, 
kat2b and tbx5a KO embryos to a similar extent (29°, 26° and 36° respectively) when 
compared to wildtype embryos (16°). This relaxation in cardiac looping was aggravated in 
kat2a, kat2b and tbx5a embryos showing a severe phenotype, where the heart was merely a 
stretched tube (56°, 54° and 64° respectively) (Fig. 5C). 
12	
	
Heart rate measurement also revealed the presence of bradycardia in KO embryos. At 48 hpf, 
heart rate for kat2a, kat2b and tbx5a KO mild embryos was slightly slower compared with 
controls (119, 111 and 109 vs 135 bpm respectively). In embryos showing a severe cardiac 
phenotype for all three knockouts, heart rate was severely diminished in comparison with 
control embryos (90, 93 and 87 vs 135 bpm) (Fig. 5D). 
Taking all these results together, the cardiac phenotype found in kat2a, kat2b and tbx5a 
knockdown embryos was validated in embryos harbouring mutations generated by the 
CRISPR-Cas9 genome-editing system. Furthermore, analysis of the cardiac phenotype in KO 
embryos confirmed the similarity between kat2a/kat2b and tbx5a mutants in terms of cardiac 
morphology, looping degree and rate of heart beat. 
	
Figure 5. CRISPR-Cas-mediated knockout of kat2a, kat2b and tbx5a in zebrafish phenocopy their knockdown counterparts. 
(A) Images of 48 hpf control embryos (injected with Cas9 only) and embryos injected with Cas9 and a sgRNA for kat2a, 
kat2b or tbx5a respectively. Embryos were categorized as mild or severe based on the severity of the cardiac phenotype. The 
heart is highlighted in a blue square, and representative in-situ hybridization images using a cmlc2 probe are shown for each 
phenotype (bottom left corner, V=ventricle, A=atrium, PE=pericardial oedema). A list of some of the mutations found in 
kat2a, kat2b and tbx5a injected embryos is shown under the relevant embryos. Target site is highlighted in yellow, and PAM 
sequence is red underlined. Deletions are highlighted in grey, insertions in blue and substitutions in green. (B) Distribution 
of cardiac phenotypes based on severity in injected embryos (n=200 embryos per injection batch). (C) Heart beating rate was 
measured in 48 hpf embryos, indicating the presence of bradycardia in kat2a, kat2b and tbx5a KOs. (D) Average looping 
angle in 48 hpf control and KO embryos. For (C) and (D), data + SEM is represented (n=10-20 embryos per phenotype). 
Relative to controls, KO embryos were statistically significant (**P < 0.001, or *P < 0.01). Scale bar = 200 µm 
Kat2a and kat2b KDs/KOs present abnormal fin development 
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In addition to playing a critical role in heart development, tbx5a is also a crucial regulator 
during fin development in zebrafish. Thus, both tbx5a knockout and knockdown embryos 
showed abnormal fin development 72 hpf: in both cases, between a 40-60% of the embryos 
lacked both pectoral fins, and approximately 15-20% of them had stumpy, shortened fins. In 
the case of kat2a and kat2b KOs/KDs, around a 30-40% of the injected embryos presented 
the same kind of stumpy fins found in tbx5a mutants, whereas only a 5-10% showed no fins. 
In double knockdown embryos for kat2a and kat2b, the percentage of embryos lacking both 
fins is increased up to 36%, which is much closer to the proportion of tbx5a mutants showing 
this phenotype (55%) (Fig. 6A and 6B). 
To further confirm the similarities between the tbx5a and kat2a/kat2b fin phenotype, we 
performed in-situ hybridization using a bmp4 probe, a typical fin marker which is also a 
tbx5a target gene during zebrafish development. In embryos showing stumpy fins for all 3 
KOs bmp4 expression level was significantly lower than in control embryos and fin size was 
smaller; whereas embryos lacking fins showed no bmp4 expression at all (Fig. 6C).  
Altogether, these results indicate that kat2a/kat2b KOs/KDs also present an abnormal fin 
phenotype comparable to that in the tbx5a mutant, further supporting a potential genetic link 
in vivo between them. 
HAT inhibitors also produce cardiac and fin defects during zebrafish development 
To further substantiate the role of acetylation during zebrafish development, we used 
Garcinol to check whether the phenotypes produced by kat2a/kat2b KOs are recapitulated by 
inhibiting the acetyltransferase activity. Following drug tritation, we found that treatment of 
zebrafish embryos with 100 µM of Garcinol for 24 hours (starting at 20 hpf) lead to cardiac 
and fin defects similar to those found in morpholino KDs and CRISPR-Cas KOs. When 
treated with Garcinol, 84% of the embryos presented a mild cardiac phenotype respectively, 
whereas only a 3% showed a severe cardiac phenotype (Fig. 7A and 7B). Further analysis 
also confirmed the presence of bradycardia and relaxation of cardiac looping in treated 
embryos (Fig 7C and 7D). With regards to fin development, embryo screening revealed that 
75% of embryos treated with Garcinol showed stumpy, shortened fins similar to those found 
in KDs and KOs (Fig. 7A). Similar results were also found when we used a different HAT 
inhibitor such as anacardic acid (data not shown). Overall, these results suggest the chemical 
inhibition of kat2b also leads to cardiac and fin defects during zebrafish development, thus 
further substantiating the role of acetylation in this process. 
Tbx5a target genes are down-regulated in kat2a and kat2b KOs 
In order to check the misregulation of tbx5a activity in vivo, we carried out qPCR analysis on 
32 hpf kat2a and kat2b KO embryos. We checked the relative mRNA levels of five different 
tbx5a transcriptional targets: fgf10, bmp4, nppa, hey2 and tbx2b. As shown in Fig. 7A, all 
five genes were significantly down-regulated in both kat2a and kat2b KO embryos. To 
further confirm the down-regulation of tbx5a target genes, we performed in-situ hybridization 
on 32 hpf kat2a and kat2b KO embryos using probes for fgf10 (a fin marker), bmp4 and nppa 
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(two different cardiac markers). ISH on fgf10 showed a down-regulation of this gene in 
kat2a/kat2b KOs in comparison to their WT counterparts in the pectoral fins among other 
tissues. In the case of nppa and bmp4, their expression levels were also reduced in the heart 
of KO embryos in comparison with their WT counterparts (Fig. 7B). 
 
 
Figure 6. Fin development is affected in kat2a and kat2b KO/KD embryos. (A) Representative images of 72 hpf control 
embryos (presenting fully-developed pectoral fins) and kat2a, kat2b and tbx5b KO/KD embryos where fin development is 
abnormal (examples of embryos with stumpy fin/s or embryos with no fins are shown for each phenotype). Black arrows 
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indicate the presence of shortened, stumpy fins. (B) Distribution of fin phenotypes in Cas9+sgRNA-injected embryos and in 
morpholino-injected embryos (n=200 embryos per injection batch). (C) In situ hybridization in 48 hpf embryos using a bmp4 
probe. In embryos presenting stumpy fins, fins are smaller and bmp4 expression level is reduced when compared to controls 
(bmp4 signal in the fins is highlighted by a dashed circle). No signal is detected in embryos lacking both pectoral fins. Scale 
bar = 200 µm  
	
Figure 7. Treatment of zebrafish embryos with acetyl-transferases inhibitor Garcinol also produces heart and fin defects. (A) 
Images of 48 hpf control embryos treated with Garcinol 100 uM. On the upper row, the heart is highlighted using a blue 
square, and representative in-situ hybridization images using a cmlc2 probe are shown for each phenotype (bottom left 
corner, V=ventricle, A=atrium). Pectoral fins are shown in the bottom row. (B) Distribution of cardiac and fin phenotypes 
based on severity in treated embryos (n=200 embryos per group).  (C) Heart beating rate was measured in 48 hpf embryos, 
indicating the presence of bradycardia in treated embryos. (D) Average looping angle in 48 hpf control and treated embryos. 
For (C) and (D), data + SEM is represented (n=10-20 embryos per phenotype). Relative to controls, treated embryos were 
statistically significant (**P < 0.001, or *P < 0.01). Scale bar = 200 µm 
Tbx5a K339Q acetyl-mimic is able to partially rescue the kat2a/kat2b KO phenotype 
Our biochemical and genetic studies suggest that kat2a and kat2b regulate tbx5a during heart 
and forelimbs development. To further confirm the in vivo link between these factors, we 
performed a rescue experiment of the kat2a KO phenotype using a tbx5a acetyl-mimic 
transcript (tbx5a K339Q). As shown in Fig. 8, co-injection of Cas9+kat2a sgRNA along with 
the acetyl-mimic mRNA leads to an increase in the number of embryos showing a normal 
cardiac phenotype in comparison with their KO counterparts (72% in the rescue group vs 
52% in the knockout group). When analysing the fin phenotype in the rescue and knockout 
groups, we also found a similar increase in the percentage of embryos showing normal fins in 
the rescue group when compared with the knockout group (75% vs 59% respectively). 
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Overall, these data support the fact that tbx5a in vivo acetylation is required for proper 
cardiac and limb development in zebrafish. 
 
Figure 8. Effect of kat2a/kat2b KO in tbx5a target genes during zebrafish development. (A) qPCR analysis showing down-
regulation of nppa, fgf10, bmp4, hey2 and tbx2b at 32 hpf in kat2a and kat2b KO embryos. Mean + SEM is represented 
(n=3). **P < 0.005, or *P < 0.05. (B) In-situ hybridization using fgf10, nppa and bmp4 probes was performed on 32 hpf 
kat2a or kat2b KO embryos. Pectoral fins (PF) are highlighted by a dashed circle, and the heart is highlighted by dashed line 
(V=ventricle, A=atrium). 
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Figure 9. Rescue of the kat2a KO phenotype was performed by injecting in vitro synthesized tbx5a K339Q mRNA. (A) 
Distribution of cardiac phenotypes (48 hpf) based on severity in control, knockout and rescue embryos is shown. (B) 
Distribution of fin phenotypes (72 hpf) based on severity (n=200 embryos per injection batch). p<0.01, chi-square test. 
DISCUSSION 
The function of TBX5 is primarily modulated  by its interacting proteins, but as recent studies 
suggest it can also be modulated by posttranslational modifications such as acetylation 
(Lewandowski et al. 2014) and sumoylation (Beketaev et al. 2014). We have identified acetyl 
modification of TBX5 and showed that modification is linked to heart and limb development. 
In cell transfection assays, we showed that both KAT2A and KAT2B physically interact with 
and acetylate TBX5, and that acetylation enhanced its transcriptional potential. Recent 
studies have linked p300 with the acetylation of Tbx5 (Lewandowski et al. 2014). However, 
we failed to detect p300-mediated acetylation of TBX5 in our experiments. The apparent 
disparity could be due to the different cell lines used in the assay systems or a very low level 
of acetylation by p300 that we were unable to detect. Acetylation and deacetylation regulate 
Tbx5-mediated gene transcription during early cardiogenesis (Lewandowski et al. 2014). 
Previous studies suggested TIP60, a MYST family histone acetyltransferase, associates with 
Tbx5 to activate the SRF promoter and that requires a functional histone acetyltransferase 
domain (Barron et al. 2005). Acetyl modification of other cardiac transcription factors such 
as GATA4 (Miska et al. 2001) and MEF2C (Kuninger et al. 2007) is thought to play an 
important role in cardiomyocyte differentiation.  
To map the acetyl lysine residue in TBX5, we employed on-line prediction tools such as 
PredMod, PAIL and PHOSIDA. Whilst the prediction varies considerably, Lys234 was 
picked up by all three tools. However, our subsequent mutagenesis studies ruled out Lys 234 
as a key target of acetylation. Similar attempts by Lewandowski et al to map the key lysine 
residues in TBX5 were unsuccessful (Lewandowski et al. 2014).  Acetylation of lysine 
residues in non-histone proteins is mostly carried out by acetyltransferases p300 and KAT2B. 
Thus far a specific molecular signature for acetylation has not been determined. Based on 
P53 acetylation, a consensus sequence K/RXKK was suggested for acetyltransferase p300 
(Gu and Roeder 1997). The HAT domain of Tetrahymena GCN5, a PCAF homologue, binds 
a specific site containing a sequence G-K-X-P on histone proteins (Rojas et al. 1999). 
However, these motifs are not present in most of the acetylated non-histone proteins 
including TBX5.  Using sequence alignment around the key lysine residues of KAT2B/2A-
mediated acetylated proteins, we derived a lysine rich consensus motif K-X-X-K-K/R-P/L/K 
as putative acetylation sites. TBX5 does not show a full-length motif but it does contain two 
partial motifs K-K/R-P/L/K at positions 325 and 339 respectively. These two partial motifs 
also overlap with recognition sequences obtained for p300 and GCN5 (Gu and Roeder 1997, 
Rojas et al. 1999). Site directed mutagenesis studies of the lysine residues in these motifs 
indicated that acetylation occurs on Lys339, which is highly conserved across species.  
TBX5 has two nuclear localization signals: NLS1 (aa78-90) and NLS2 (aa325-340), which 
act in a cooperative fashion (Collavoli et al. 2003). Lys 339 is located in NLS2 of TBX5.  
Our results demonstrate that the acetylation-deficient mutant TBX5-K339R accumulates 
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mostly in the cytoplasm, and treatment with TBX5-WT with Garcinol led to the same defect 
in cellular distribution. This impairment in nuclear localization could be due to two different 
reasons: a defect in nuclear import or an enhanced nuclear export. Leptomycin B treatment of 
the acetyl-deficient TBX5-K339R variant lead to its nuclear accumulation, thus suggesting 
this mutant is still able to get into the nucleus, but it is not retained inside. The nuclear export 
of TBX5 occurs through exportin CRM1, which interacts with an evolutionarily conserved 
nuclear export signal (NES) at 152-160 (Kulisz and Simon 2008). Indeed, co-localization 
studies showed that TBX5-K339R and CRM1 interact outside the nucleus. In order to 
understand how acetylation could regulate CRM1-mediated export of TBX5, we performed 
pull-down studies. The results suggest that the acetyl-deficient TBX5K339R presents higher 
affinity for CRM1 than its WT counterpart.  
The TBX5 acetylation site within NLS2, when not acetylated, appears to promote TBX5 
nuclear export via the CRM1-pathway. This kind of mechanism has been described 
elsewhere: acetylation of several proteins such as HNF-4, POP-1 or CtBP2 within their 
respective NLS leads to their nuclear retention by inhibiting CRM1-mediated export 
(Soutoglou et al. 2000, Gay et al. 2003, Zhao et al. 2006). As acetylation enhances its nuclear 
retention, that increases the nuclear pool of TBX5 leading to enhanced transcriptional 
activity. Lack of TBX5 acetylation increases its affinity for the CRM1 exportin, which leads 
to its efficient nuclear export and subsequently reduces its transcriptional activity.  
To examine the in vivo role of kat2a and kat2b we performed gene knock-down and knock-
out experiments in zebrafish at early stages of development and examined the phenotypic 
consequences. Both morpholino-mediated knockdown and CRISPR-Cas-mediated knockout 
of kat2a or kat2b produced unlooped elongated hearts and stumpy fin phenotypes, similar to 
those observed in tbx5 morphants and mutants, suggesting that both may work in a common 
pathway of heart and limb development. The main difference between the phenotype of 
kat2a/kat2b mutant embryos and that of tbx5a mutants lies in the severity of the phenotype. 
Most of kat2a and kat2b single knockouts present a mild cardiac phenotype, whereas most of 
tbx5a mutants show a more severe cardiac phenotype. Several publications have previously 
suggested that Kat proteins present functionally overlapping roles (Jin et al. 2011, Jin et al. 
2014), and mice lacking both Kat2a and Kat2b die at an earlier stage than Kat2a single KO 
mice (Yamauchi et al. 2000). Based on our data, knockdown of both zebrafish kat proteins 
also lead to the presence of a greater number of embryos presenting a severe phenotype, 
supporting a potential redundant effect between kat2a and kat2b.  
kat2a and kat2b KO/KD also present abnormal fin development, one of the main phenotypic 
features of tbx5a mutants. Most of kat2a or kat2b mutants developed fins but they were 
abnormal in shape or size, whereas tbx5a mutants lacked both fins in most cases. Knockdown 
of both kat proteins increased the number of embryos lacking both fins, a result in 
concordance with the kat2a and kat2b redundancy. In addition to this, we have also further 
substantiated the role of acetylation during development by inhibiting the acetyltransferase 
activity on zebrafish embryos. Treatment with Garcinol (HAT inhibitor) lead to cardiac and 
fin defects similar to those found on kat2a and kat2b knock-down and knock-out embryos. 
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Most of the embryos treated with Garcinol showed mild defects, suggesting this that this 
compound do not completely abolish the acetyltransferase activity (Garcinol is predicted to 
exclusively target KAT2B and p300 acetyltransferases). 
In order to provide evidence that loss of tbx5a acetylation is indeed responsible for the 
kat2a/kat2b phenotype, we performed qPCR and ISH analysis of typical tbx5a target genes, 
including nppa, fgf10, bmp4, hey2 and tbx2b, which have been showed to be downregulated 
in a tbx5a KO context in the past (Parrie et al. 2013, Puskaric et al. 2010, Zhao et al. 2015). 
Both approaches confirmed the down-regulation of tbx5a targets in both kat2a and kat2b KO 
embryos. To further support an in vivo link between tbx5a and kat2 proteins, we attempted to 
rescue the kat2a KO phenotype using a tbx5a K339Q acetyl-mimic. Glutamine is an effective 
mimic of acetylated lysine due to the similarity of charge and chemical structure, and it can 
function as acetylated lysine in vivo (Li et al. 2002, Wang and Hayes 2008). Indeed, injection 
of K339Q variant lead to a partial rescue of both the cardiac and fin phenotype in kat2a KO 
embryos. These results suggest that loss of tbx5a acetylation is mainly responsible for the 
cardiac and fin abnormalities present in our kat2a/kat2b knock-down and knock-outs. 
In summary, both in vitro and in vivo data support the notion that KAT2A and KAT2B 
acetyltransferases are tightly linked to TBX5 and control its transcriptional activity, thus 
leading to abnormal cardiac and upper limb development. Our studies suggest that K339 is 
important and provide insight into a new mechanism of TBX5 activity regulation in which 
acetylation is required for its nuclear retention and for maintaining a critical concentration 
inside the nucleus. Although a large number of TBX5 mutations have been identified in cases 
of HOS, no mutation has been reported at lysine 339 thus far. However, we would predict 
that non-acetylation of TBX5 would likely cause or contribute to functional deficiency that 
may lead to HOS in humans.  
MATERIALS AND METHODS 
Plasmids Construction   
A FLAG tagged TBX5 PCR product was generated from plasmid pcDNA-TBX5 described 
previously (Ghosh et al. 2001) and cloned into NheI and BamHI of pcDNA3.1 (Invitrogen) to 
give rise to pcDNA-TBX5-FLAG. KAT2A-HA and CRM1-HA PCR products were 
generated from IMAGE clones 6137532 and 5267242 (Source Bioscience, UK) respectively. 
The PCR products were then digested and cloned into NheI and XhoI sites of pcDNA3.1 to 
generate pcDNA-KAT2A-HA and pcDNA-CRM1-HA respectively. We generated pcDNA-
KAT2B-HA by subcloning KAT2B-HA from pBSSK-KAT2B-HA into XhoI and XbaI sites 
of pcDNA3.1. Generation of promoter-reporter plasmid pGL3-MYH6-I and pGL3-ANF was 
reported previously (Ghosh et al. 2001, Ching et al. 2005). Plasmid pGL3-CX40 was a gift 
from Mauro W. Costa. Plasmid pEGFP-TBX5 was generated by cloning TBX5 into Nhe I 
site of pEGFP-C1 vector (Clontech). 
Acetylation  
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The wild type or mutant FLAG-tagged TBX5 plasmids were cotransfected with or without 
pcDNA-p300-FLAG, pcDNA-KAT2B-HA or pcDNA-KAT2A-HA constructs in Cos7 cells. 
Cell lysates were generated from 48h post transfected cells in cell lysis buffer (150mM NaCl, 
20 mM Tris (pH-7.6), 1% NP-40, 1 mM PMSF, 1 µg/mL aprotinin, 1 µg/mL pepstatin, 1 
µg/mL leupeptin, 0.5mM EDTA and 0.25% deoxycholate). TSA (0.3µM) was added to the 
plates 2h prior to harvest. Initially, cells were harvested from two 100 mm plates in PBS, 
pelleted down and resuspended in 200ul of lysis buffer. The cell suspensions were then 
placed under ice for 1h followed by brief sonication. TBX5-FLAG proteins were partially 
purified on Anti-FLAG M2 affinity gels (Sigma), extracted with NuPAGE LDS sample 
buffer (Life Technologies) and fractionated on NuPAGE 10% Bis-Tris gels (Life 
technologies) followed by Western blotting. Acetylated proteins were detected using anti-
acetylated lysine antibody (Cell Signaling). FLAG-TBX5 proteins were detected on the same 
blot using Anti-FLAG M2 antibody (Sigma). The expression level of KAT2B/KAT2A in the 
extracts was detected using monoclonal Anti-HA antibody (Sigma).  
In order to perform in vitro acetylation assays we overexpressed TBX5 as MBP-TBX5 in 
bacteria and partially purified on Amylose resin. We obtained purified recombinant KAT2B 
protein from Abcam. Acetylation assays were performed as described previously (Kuninger 
et al. 2007). 
Pull-down Assay  
Cell extracts were incubated with 20-30ul of washed Anti-FLAG M2-Affinity gel (Sigma) at 
40C. For interaction studies, cell lysates were added to the affinity gel and incubated for 2h or 
overnight in a shaker at 40C. To remove non-specific proteins, beads were washed 6 times in 
wash buffer (20mM Tris (pH7.6), 150mM NaCl, 0.5% NP40 and 0.5mM EDTA). Bound 
proteins were specifically eluted from the beads with wash buffer (15.0 µl) containing 3X 
FLAG peptide (Sigma). Eluted proteins were fractionated on 10% Bis-Tris gel followed by 
Western blotting. FLAG-tagged and HA-tagged proteins were detected using Anti-FLAG M2 
antibody (Sigma) and monoclonal Anti-HA antibody (Sigma) respectively. Endogenous 
levels of Kat2b and Kat2a were detected using anti-KAT2B (Cell Signaling) and anti-
KAT2A (abcam) antibodies respectively. Anti-α Tubulin (Santa Cruz) was used to detect 
housekeeping protein tubulin. Detection of CRM1 protein was carried out with anti-CRM1 
antibody (Santa Cruz). Semi-quantitative analysis of the bands was performed using the 
software ImageJ. 
Cell Culture, Transfection and Reporter Assay 
 Cos7 and H9c2 cells were transfected using Polyfect (Qiagen) according to the 
manufacturer’s protocol. C2C12 cells were nucleofected using nucleofector kit V (Lonza). 
For pull-down assays we used Cos7 cells and transfections were performed using 6 µg of 
each plasmid DNA in 100 mm tissue culture dishes.  Reporter assays were carried out in 
H9c2 cells using 1.5µg reporter plasmid pGL3-MYH6-I, 1.0 µg of pcDNA-TBX5 or 
pcDNA-TBX5K339R, 1.0 µg pcDNA-KAT2B or pcDNA-KAT2A, and 4 ng of pRL-TK was 
used as an internal control to normalize variation in transfection efficiency between the 
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plates. Luciferase assays were carried out on cell lysates using dual luciferase assay kit 
(Promega) in duplicates and each experiment was carried out at least three times. Values 
were obtained as means ± S.D. Significance analysis was performed using student’s t test.  
 
Site-Directed Mutagenesis 
Site directed mutagenesis was carried out using the QuickChange Site Directed Mutagenesis 
Kit (Agilent Technologies). pcDNA-TBX5-FLAG was used as a template to generate the 
mutants K234R, K325R, K327R, K339R and K340R.  
RT-PCR Analysis  
Wild type zebrafish embryos were isolated and collected at various developmental stages; 
they were subsequently dissected using surgical microlances to produce tail and head/thorax 
sections. The dissected sections were collected on dry ice and immediately frozen for storage 
prior to processing. Total RNA was isolated from pools of 50-100 zebrafish embryos of the 
respective section using TRI-Reagent according to manufacturer’s instructions. DNase 
treatment was carried out at 37˚C for 30 minutes. First strand cDNAs were synthesised from 
1µg of Total RNA with M-MuLV Reverse Transcriptase in a final volume of 20µl including 
1 x RT Buffer, 1Mm dNTPs, RNase Inhibitor, 2µl of random hexamers and made up with 
DEPC water. The reaction mixture was incubated at 42˚C for 1 hour and the enzyme 
deactivated at 90˚C for 10 minutes. The following primers were used for zebrafish to detect 
the expression of kat2a and kat2b and a reference control gene β-actin1. 
kat2bF: GGTACGAGGCCACACAGATT ; kat2bR: GTAGGAAACATCCGGAAGCA  
kat2aF: CCTAAGCCAACAGCAATGGT ; kat2aR: GCTTGGTGTCCGTGTCTTCT 
β-actin1F: ACATCAGCATGGCTTCTGCT; β-actin1R: GTGTACAGAGACACCCTGGC.  
PCR amplification was performed in 25µl reactions containing final concentration of 1x 
standard Taq reaction buffer, 200µM dNTPs, 0.2µM primers, 1.25U of Taq enzyme, 1µl of 
resultant cDNA and made up with Nuclease- free water. Thermocycling conditions were an 
initial denaturation of 30 seconds at 95˚C followed by 35 cycles of 30 seconds of 
denaturation, 30 seconds annealing at 59˚C and 50 seconds of elongation at 68˚C followed by 
a final extension time of 5 minutes at 68˚C. RT-PCR products were resolved by 
electrophoresis on 1.5% agarose gels and visualized with ethidium bromide. 
Immunofluorescence and cell imaging:  
Cos7 cells were grown on coverslips in 6 well plates overnight and transfected with TBX5-
WT-FLAG or TBX5-K339R-FLAG constructs using polyfect (Qiagen). C2C12 cells were 
transfectd using Amaxa Cell Line Nucleofector kit V according to manufacturer’s protocol 
(Lonza). When required, transfected cells were treated with 10 nM of leptomycin B or 20 µM 
of Garcinol 16 hours before fixation. Twenty four hours posttransfection cel
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phosphate buffer saline (PBS, pH 7.4), fixed with 4% paraformaldehyde for 10mins and 
washed in PBS three times, 5 minutes each. Cells were then permeabilized with 0.25% Triton 
X-100 in PBS for 5 minutes washed in PBS three times and incubated in 10% BSA in PBS 
for 1 hour at room temperature to supress non-specific binding of IgG.  After blocking the 
cells were washed in PBS and incubated with mouse monoclonal antibody against FLAG 
(Sigma, F1804, dilution 1:300) or with rabbit anti-human CRM1 antibody (SantaCruz, sc-
74454, dilution 1:50) in PBS containing 3% BSA for 2 hours at room temperature. Cells were 
washed three times in PBS each for 5 minutes and incubated in 3% BSA in PBS containing 
secondary antibody Alexa Fluor 488 goat anti-rabbit IgG (Life Technology, 2µg/ml) for 45 
minutes at room temperature. Then cells were washed three times in PBS each for 5 minutes 
and the washed coverslips were mounted on glass slides containing a small drop of mounting 
media containing DAPI (Vectashield). Laser scanning confocal microscopy was performed 
on LSM 880F (Carl Zeiss, Oberkochen, Germany) using a 63X 1.4 oil objective. 
Knockdown and Knockout Experiment in Zebrafish 
Wildtype zebrafish were raised and maintained as described by Westfield (Westfield 1993). 
Initially to assess the function/phenotype of kat2a and kat2b we used antisense morpholino 
oligonucleotides to block translation. These were designed and made by Gene Tools: kat2a 
5’-TCCGCCATAACAGCAGCCACACTTC-3’ and kat2b 5’-
GATCCCCGTGCTTTCCGACATCGAA-3’. Two additional morpholinos were designed to 
target the intron1-exon2 splice sites in both genes respectively: kat2a splice 5’-
ATTCGCCTGAGATAAGAAGAGTGCA-3’, kat2b splice 5’-
TCAGCCTGTGTGAAAGAAAGAAGAGTGCA-3’ (Gene Tools). All morpholinos were 
injected at 1-8 cell stage and mismatch morpholino-injected siblings were used as controls. In 
order to generate kat2a, kat2b and tbx5a knockouts using the CRISPR-Cas system, sgRNAs 
for each target gene were designed using the web tool CHOPCHOP 
(http://chopchop.cbu.uib.no/).  DNA template for sgRNA transcription was generated using a 
cloning-free method previously described (Moreno-Mateos et al. 2015). Approximately 150 
ng of template was used for sgRNA in vitro transcription using a MAXIscript T7 
transcription kit (Ambion) and quality was examined using a 2100 Bioanalyzer (Agilent 
Technologies). Subsequently, 100 pg of sgRNA and 500 pg of Cas9 protein (NEB) were 
injected into 1-cell stage zebrafish embryos and Cas9-only injected embryos were used as 
controls. The injected embryos and controls were kept at 28.5°C for 2 or 3 days post-
fertilization. The images of live 2/3-day-postfertilization zebrafish were captured using a 
Zeiss Stereo Lumar V12 microscope with a camera. Phenotypic severity was categorized into 
three groups: normal, mild and severe.  
Drug treatment 
In order to chemically inhibit the acetyltransferase activity, we used Garcinol (Santa-Cruz 
Biotechnology). First, pools of 10-15 embryos were treated using a range of different 
concentrations (0.1 to 500 µM) to find which gave a reproducible and consistent phenotype 
without compromising viability. Treatments were carried out for 24 hours starting at 20-24 
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hpf (initial stages of cardiogenesis). Embryos were washed at 48 hpf to remove the drug and 
they were subsequently screened for cardiac or fin defects.  
Quantitative PCR 
Expression levels of tbx5a target genes were measured using a 7500 Real-Time PCR system 
(Applied Biosystems). Total RNA was extracted from 32 hpf kat2a, kat2b and tbx5a KO 
embryos for posterior cDNA synthesis and qPCR analysis. Two well established zebrafish 
housekeeping genes, ef1a and lsm12b, were used for normalization. The following primers 
were used for the detection of nppa, fgf10, bmp4, hey2, tbx2b, ef1a and lsm12b expression 
levels: 
nppaF: CAGACACAGCTCTGACAGCAACAT; nppaR: 
CTCTGTGTGTCAAATCCATCCGAG 
fgf10F: CTCATCGTCTGCCGTGGTG; fgf10R: GTCAATGCCGAAATCCCTC 
bmp4F: CACAGTATCTGCTCGACCTCTA; bmp4R: 
GATATGAGTTCGTCCTCTGGGATG 
hey2F: GAAAGAAGCGGAGAGGGATCATTG; hey2R: 
AGAAGTCCATGGCCAGAGAATGAG 
tbx2bF: GTCCCTTTCCCTTTCATCTGTCTC; tbx2bR: 
CTGGGAGCTGATAAGGGTTGAATC  
ef1aF: CGGTGACAACATGCTGGAGG; ef1aR: ACCAGTCTCCACACGACCA 
lsm12bF; AGTTGTCCCAAGCCTATGCAATCAG; lsm12bR: 
CCACTCAGGAGGATAAAGACGAGTC 
Rescue experiment 
For rescue experiments, we synthesised capped mRNA transcripts from the SP6 promoter of 
linearized plasmid pCS2-TBX5A-K339Q (previously generated by cloning) using mMessage 
mMachine kit (Ambion). 300 pg of tbx5a K339Q mRNA were co-injected with 100 pg of 
sgRNA and 500 pg of Cas9 protein (NEB) into 1-cell stage zebrafish embryos. Injected 
embryos were screened 48 and 72 hpf for the presence of cardiac and fin defects. 
In-situ hybridization and cardiac looping measurement 
In order to study heart and fin morphology, injected embryos were fixed overnight in 4% 
paraformaldehyde solution in PBS (PFA) and subjected to in-situ hybridization according to a 
method previously described (Thisse and Thisse 2008). Cardiac looping angle was 
determined by measuring the angle formed by the plane of the atrioventricular junction (AVJ) 
relative to the anterior/posterior axis of the embryo (Chernyavskaya et al. 2012).  
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